Mankind Pharma 35th AGM on Aug 4, 2026; notice and annual report filed

Board & Shareholder Meetings View source PDF

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.4%1-day move

₹2540.00

prior close

₹2543.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.4-0.4-0.2+0.1-1.4-0.5+0.0+0.4-2.4+1.4————

Up moveDown movePending

AI summary

Mankind Pharma has notified the 35th AGM on August 4, 2026 at 3:30 PM via video conferencing, along with the annual report for FY 2025-26. E-voting runs August 1-3, with cut-off date July 29. Resolutions include adoption of audited financial statements, re-appointment of Vice Chairman Rajeev Juneja retiring by rotation, re-appointment of Whole Time Director Satish Kumar Sharma for 5 years at Rs 1.32 crore per annum, and ratification of cost auditor remuneration of Rs 25.50 lakh for FY 2026-27.

Likely market impact

Routine AGM notice. Shareholders can vote on director re-appointments and approve FY 2025-26 accounts from August 1.